66P Targeted treatment (TT) after immune checkpoint inhibitors (ICIs) in BRAF V600E mutated (BRAFm) and deficient mismatch repair or microsatellite instability high (dMMR/MSI-H) metastatic colorectal cancer (mCRC)
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.05.077